Głowacka, U.; Magierowski, M.; Śliwowski, Z.; Cieszkowski, J.; Szetela, M.; Wójcik-Grzybek, D.; Chmura, A.; Brzozowski, T.; Wallace, J.L.; Magierowska, K.
Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries. Antioxidants 2023, 12, 1545.
https://doi.org/10.3390/antiox12081545
AMA Style
Głowacka U, Magierowski M, Śliwowski Z, Cieszkowski J, Szetela M, Wójcik-Grzybek D, Chmura A, Brzozowski T, Wallace JL, Magierowska K.
Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries. Antioxidants. 2023; 12(8):1545.
https://doi.org/10.3390/antiox12081545
Chicago/Turabian Style
Głowacka, Urszula, Marcin Magierowski, Zbigniew Śliwowski, Jakub Cieszkowski, Małgorzata Szetela, Dagmara Wójcik-Grzybek, Anna Chmura, Tomasz Brzozowski, John L. Wallace, and Katarzyna Magierowska.
2023. "Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries" Antioxidants 12, no. 8: 1545.
https://doi.org/10.3390/antiox12081545
APA Style
Głowacka, U., Magierowski, M., Śliwowski, Z., Cieszkowski, J., Szetela, M., Wójcik-Grzybek, D., Chmura, A., Brzozowski, T., Wallace, J. L., & Magierowska, K.
(2023). Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries. Antioxidants, 12(8), 1545.
https://doi.org/10.3390/antiox12081545
